Clinical Trial Update: MAPS & ITEC Cohorts: 6-8 Years Follow-up [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update with long-term follow-up completed for MAPS & ITEC cohorts.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Snippet

Sponsor: University of Southampton | Conditions: Immunotherapy, Allergy and Immunology | Phase 2 | Status: COMPLETED